Eiseman JL, Effect of honeybee venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat,

Barbara Rudolf, Chemistry and pharmacology of honey bee venom, Academic Press

Habermann E, (1971;3) pharmacology and toxicology of bee, Academic Press

Lee JH, (2000) Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carrageenan- induced inflammation,

Keystone E,, (1998) IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis,

Woods JM,, (1999) Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo,

Bugawan TL,, (2003) Association and interaction of the IL4R and IL13 loci with type 1 diabetes among Filipinos,

Mirel DB, , (2002) Association of IL4R haplotypes with type 1 diabetes,

Caldwell JR, (1999) Venoms, copper, and zinc in the treatment of arthritis,

Lee JS,, (2000) A study on major components of bee venom using HPLC,

Wieser F,, (2003) Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing,

Gruber JD,, (2002) Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing,

Qiu P,, (2003) Quantification of single nucleotide polymorphisms by automated DNA sequencing,

Pettersson M, (2003) Molecular haplotype determination using allele-specific PCR and pyrosequencing technology. ,

Pacey-Miller , (2003) Single-nucleotide polymorphism detection in plants using a single-stranded pyrosequencing protocol with a universal biotinylated primer,

Kwon YB, , (2002) The water-soluble fraction of bee venom produces antinoceiceptive and anti-inflammatory effects on rheumatoid arthritis in rats,

Kwon YB, (2001) Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses,

Kim JG, (1989;10) Study on the acupuncture moxibustion and herbal-acupuncture with gentianae macrophyllae radix extract solution upon the adjuvant arthritis in rats J of Korean acupuncture & Moxibution society,

Lipsky PE,, (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis,

Arend WP,, (2000) Biological role of interleukin 1 receptor antagonist isoforms,

Weckmann AL,, (1996) Cytokine inhibitors in autoimmune disease,

MacKay K,, (2003) Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology (Oxford). 2003;42(1)149-53. ,

Howard TD,, (2002) Gene-gene interaction in asthma IL4RA and IL13 in a Dutch population with asthma,

Dupuy d'Angeac A, (1990;33) Low levels of interleukin 4 and high levels of transforming growth factor ß in rheumatoid synovitis,

Moreau J-F, (1994;37) Interleukin 4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis,

Bidwell J, (1999) Cytokine gene polymorphism in human disease: on-line databases. ,

Hershey GK, (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor,

Bennett B, (1991;174) inhibits cytokine synthesis by human monocytes an autoregulatory role of IL-10 produced by monocytes,

Garcia E, (1992;891890-3) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes,

Chu CQ, (jexpmed1994;179) Immunoregulatory role of interleukin 10 in rheumatoid arthritis,

Eskdale J, , (1997) Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence,

Crawley E, , (1999) Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis,

Huizinga TW,, (2000) Are differences in interleukin 10 productiassociated with joint damage? Rheumatology,

Eskdale J,, (1999) Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. ,

D'Alfonso S,, (2000) New polymorphisms in the IL-10 promoter region,

Turner DM,, (1997) An investigation of polymorphism in the interleukin-10 gene promoter,

Barton A, (2003) Approaches to identifying genetic predictors of clinical outcome in rheumatoid arthritis,

Padyukov L, , (2003) Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis,